Commentary

Sodium vs Potassium for Lowering Blood Pressure?


 

No Salt War Here

Despite their different editorial takes, Dr. Hiremath and Dr. Juraschek largely agree on the broad strokes of the problem. This isn’t X (or Twitter) after all. Potassium supplementation may be useful in some parts of the world but may not address the underlying problem in countries where processed foods are the source of most dietary sodium.

The CARDIA-SSBP trial showed that a very low–sodium diet had the same blood pressure–lowering effect as a first-line antihypertensive, but most people will not be able to limit themselves to 500 mg of dietary sodium per day. In CARDIA-SSBP, just as in DASH, participants were provided with meals from study kitchens. They were not just told to eat less salt, which would almost certainly have failed.

“We should aim for stuff that is practical and doable rather than aim for stuff that cannot be done,” according to Dr. Hiremath. Whether that should be salt substitutes or policy change may depend on which part of the planet you live on.

One recent positive change may herald the beginning of a policy change, at least in the United States. In March 2023, the US Food and Drug Administration proposed a rule change to allow salt substitutes to be labeled as salt. This would make it easier for food manufacturers to swap out sodium chloride for a low-sodium alternative and reduce the amount of sodium in the US diet without having a large impact on taste and consumer uptake. Both Dr. Hiremath and Dr. Juraschek agree that it may not be enough on its own but that it’s a start.

Christopher Labos is a cardiologist with a degree in epidemiology. He spends most of his time doing things that he doesn’t get paid for, like research, teaching, and podcasting. Occasionally, he finds time to practice cardiology to pay the rent. He realizes that half of his research findings will be disproved in 5 years; he just doesn’t know which half. He is a regular contributor to the Montreal Gazette, CJAD radio, and CTV television in Montreal, and is host of the award-winning podcast The Body of Evidence.

A version of this article appeared on Medscape.com.

Pages

Recommended Reading

Report: CKD Severity Linked to Thinning of Retina, Choroid Layers
MDedge Internal Medicine
Can a Healthy Gut Microbiome Prevent Kidney Stones?
MDedge Internal Medicine
Redosing Rituximab to Maintain ANCA Vasculitis Remission: When Is Best?
MDedge Internal Medicine
Evidence Grows for SGLT2 Inhibitors in Rheumatology
MDedge Internal Medicine
Strict Glycemic Control for Renal Benefit May Come With Risk
MDedge Internal Medicine
Why Is Kidney Disease So Often Missed?
MDedge Internal Medicine
EHR Tool Enhances Primary Aldosteronism Screening in Hypertensive Patients
MDedge Internal Medicine
Hypocalcemia Risk Warning Added to Osteoporosis Drug
MDedge Internal Medicine
High Salt Intake Linked to Increased Risk for Kidney Disease
MDedge Internal Medicine
Insulin Resistance Doesn’t Affect Finerenone’s Efficacy
MDedge Internal Medicine